Literature DB >> 17531851

Gender issues in multiple sclerosis.

Robert N Schwendimann1, Nadejda Alekseeva.   

Abstract

Multiple sclerosis (MS) varies considerably in the way that it affects females and males. The prevalence of the disease is much greater in women and tends to follow a different clinical course than it follows in the affected male population. It is also well known that MS symptoms often are much less of a problem during pregnancy. This chapter discusses possible explanations for gender differences based on sex hormones as well as the effects of these hormones on cytokines and other factors that may influence the course of MS. Knowledge of these effects may hold some promise in other types of treatment for MS. Since MS is much more prevalent in women of child-bearing age, there are also implications for the use of disease-modifying agents as well as drugs and treatments that may be useful for treatment of MS. MS often causes symptoms of sexual dysfunction, but there may be effective treatment for many of these treatments.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17531851     DOI: 10.1016/S0074-7742(07)79017-7

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  17 in total

1.  Theiler's virus infection: Pathophysiology of demyelination and neurodegeneration.

Authors:  Fumitaka Sato; Hiroki Tanaka; Faris Hasanovic; Ikuo Tsunoda
Journal:  Pathophysiology       Date:  2011-02

Review 2.  Central and peripheral neuroimmune responses: hyporesponsiveness during pregnancy.

Authors:  Sarah J Spencer; Abdeslam Mouihate; Michael A Galic; Quentin J Pittman
Journal:  J Physiol       Date:  2007-10-18       Impact factor: 5.182

Review 3.  Effects of the Menstrual Cycle on Neurological Disorders.

Authors:  Hannah J Roeder; Enrique C Leira
Journal:  Curr Neurol Neurosci Rep       Date:  2021-05-10       Impact factor: 5.081

4.  Multimodal analysis in acute and chronic experimental autoimmune encephalomyelitis.

Authors:  Silvia Giatti; Mariaserena Boraso; Federico Abbiati; Elisa Ballarini; Donato Calabrese; Maria Santos-Galindo; Roberta Rigolio; Marzia Pesaresi; Donatella Caruso; Barbara Viviani; Guido Cavaletti; Luis Miguel Garcia-Segura; Roberto Cosimo Melcangi
Journal:  J Neuroimmune Pharmacol       Date:  2012-06-30       Impact factor: 4.147

5.  Multiparity improves outcomes after cerebral ischemia in female mice despite features of increased metabovascular risk.

Authors:  Rodney M Ritzel; Anita R Patel; Monica Spychala; Rajkumar Verma; Joshua Crapser; Edward C Koellhoffer; Anna Schrecengost; Evan R Jellison; Liang Zhu; Venugopal Reddy Venna; Louise D McCullough
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-23       Impact factor: 11.205

Review 6.  Sex differences in cognitive impairment and Alzheimer's disease.

Authors:  Rena Li; Meharvan Singh
Journal:  Front Neuroendocrinol       Date:  2014-01-13       Impact factor: 8.606

7.  Neuroinflammation resulting from covert brain invasion by common viruses - a potential role in local and global neurodegeneration.

Authors:  Jeannine A Majde
Journal:  Med Hypotheses       Date:  2010-03-16       Impact factor: 1.538

Review 8.  Sex steroids and stem cell function.

Authors:  Rinki Ray; Nathan M Novotny; Paul R Crisostomo; Tim Lahm; Aaron Abarbanell; Daniel R Meldrum
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

9.  Mechanisms and pharmacology of neuropathic pain in multiple sclerosis.

Authors:  T Iannitti; B J Kerr; B K Taylor
Journal:  Curr Top Behav Neurosci       Date:  2014

10.  27-Hydroxycholesterol: a potential endogenous regulator of estrogen receptor signaling.

Authors:  Carolyn D DuSell; Donald P McDonnell
Journal:  Trends Pharmacol Sci       Date:  2008-08-22       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.